Sinil Pharmaceutical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 16,507.45 million compared to KRW 15,766.11 million a year ago. Net income was KRW 1,733.66 million compared to KRW 1,939.44 million a year ago. Basic earnings per share from continuing operations was KRW 155.3398 compared to KRW 173.7864 a year ago. Basic earnings per share was KRW 155.3398 compared to KRW 173.7864 a year ago. For the nine months, sales was KRW 593.39 million compared to KRW 596.75 million a year ago. Net income was KRW 4,107.9 million compared to KRW 6,450.71 million a year ago. Basic earnings per share from continuing operations was KRW 368.932 compared to KRW 579.6117 a year ago. Basic earnings per share was KRW 368.932 compared to KRW 579.6117 a year ago.